Trust Point Inc. Invests $1.32 Million in Cencora, Inc. $COR

Trust Point Inc. acquired a new stake in shares of Cencora, Inc. (NYSE:COR) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,223 shares of the company’s stock, valued at approximately $1,320,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in Cencora during the second quarter valued at approximately $695,215,000. Artisan Partners Limited Partnership bought a new stake in shares of Cencora during the 2nd quarter worth $411,888,000. Vanguard Group Inc. boosted its holdings in shares of Cencora by 5.3% during the 2nd quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock worth $6,740,340,000 after buying an additional 1,125,661 shares during the period. Viking Global Investors LP grew its stake in Cencora by 95.0% in the 2nd quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after buying an additional 1,013,913 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Cencora by 228.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 974,505 shares of the company’s stock worth $292,207,000 after acquiring an additional 677,952 shares during the period. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Cencora

In other news, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $366.64, for a total value of $1,868,397.44. Following the completion of the transaction, the chief executive officer owned 65,746 shares in the company, valued at approximately $24,105,113.44. This represents a 7.19% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 10.80% of the stock is owned by company insiders.

Cencora Trading Up 0.1%

Shares of COR opened at $341.07 on Friday. The stock’s 50-day moving average price is $346.49 and its 200 day moving average price is $313.16. The company has a quick ratio of 0.55, a current ratio of 0.90 and a debt-to-equity ratio of 4.32. The firm has a market capitalization of $66.16 billion, a price-to-earnings ratio of 42.90, a P/E/G ratio of 1.62 and a beta of 0.63. Cencora, Inc. has a 12-month low of $223.92 and a 12-month high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, topping the consensus estimate of $3.79 by $0.05. The company had revenue of $83.73 billion for the quarter, compared to analyst estimates of $83.36 billion. Cencora had a return on equity of 227.15% and a net margin of 0.48%.Cencora’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter last year, the firm earned $3.34 EPS. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. As a group, research analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were issued a $0.60 dividend. This is a boost from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend was Friday, November 14th. This represents a $2.40 annualized dividend and a yield of 0.7%. Cencora’s payout ratio is presently 30.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Wall Street Zen cut shares of Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. Evercore ISI set a $400.00 target price on Cencora and gave the company an “outperform” rating in a research note on Thursday, November 6th. Robert W. Baird set a $392.00 price target on Cencora in a research report on Tuesday. JPMorgan Chase & Co. upped their price target on Cencora from $344.00 to $417.00 and gave the stock an “overweight” rating in a report on Tuesday, November 11th. Finally, Wells Fargo & Company raised their price objective on shares of Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and an average target price of $373.25.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.